Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2012

Open Access 01-12-2012 | Research article

Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models

Authors: Tullayakorn Plengsuriyakarn, Vithoon Viyanant, Veerachai Eursitthichai, Porntipa Picha, Piengchai Kupradinun, Arunporn Itharat, Kesara Na-Bangchang

Published in: BMC Complementary Medicine and Therapies | Issue 1/2012

Login to get access

Abstract

Background

Chemotherapy of cholangiocarcinoma (CCA), a devastating cancer with increasing worldwide incidence and mortality rates, is largely ineffective. The discovery and development of effective chemotherapeutics is urgently needed.

Methods/Design

The study aimed at evaluating anticancer activities, toxicity, and pharmacological activities of the curcumin compound (CUR), the crude ethanolic extracts of rhizomes of Zingiber officinale Roscoe (Ginger: ZO) and Atractylodes lancea thung. DC (Khod-Kha-Mao: AL), fruits of Piper chaba Hunt. (De-Plee: PC), and Pra-Sa-Prao-Yhai formulation (a mixture of parts of 18 Thai medicinal plants: PPF) were investigated in animal models. Anti-cholangiocarcinoma (anti-CCA) was assessed using CCA-xenograft nude mouse model. The antihypertensive, analgesic, anti-inflammatory, antipyretic, and anti-ulcer activities and effects on motor coordination were investigated using Rota-rod test, CODA tail-cuff system, writhing and hot plate tests, carrageenan-induced paw edema test, brewer's yeast test, and alcohol-induced gastric ulcer test, respectively. Acute and subacute toxicity tests were performed according to the OECD guideline for testing of chemicals with modification.

Results

Promising anticancer activity against CCA in nude mouse xenograft model was shown for the ethanolic extract of AL at all oral dose levels (1000, 3000, and 5000 mg/kg body weight) as well as the extracts of ZO, PPF, and CUR compound at the highest dose level (5000, 4000, and 5000 mg/kg body weight, respectively). PC produced no significant anti-CCA activity. Results from acute and subacute toxicity tests both in mice and rats indicate safety profiles of all the test materials in a broad range of dose levels. No significant toxicity except stomach irritation and general CNS depressant signs were observed. Investigation of pharmacological activities of the test materials revealed promising anti-inflammatory (ZO, PPF, and AL), analgesic (CUR and PPF), antipyretic (CUR and AL), antihypertensive (ZO and AL), and anti-ulcer (CUR, ZO, and AL) activities.

Conclusion

Plants used in Thai traditional medicine for the treatment of various ailments may provide reservoirs of promising candidate chemotherapeutics for the treatment of CCA.
Appendix
Available only for authorised users
Literature
1.
Hejna M, Pruckmayer M, Raderer M: The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer. 1998, 34 (7): 977-986. 10.1016/S0959-8049(97)10166-6.CrossRefPubMed
2.
Gao PF, Watanabe K: Introduction of the World Health Organization project of the International Classification of Traditional Medicine. Zhong Xi Yi Jie He Xue Bao. 2011, 9 (11): 1161-1164. 10.3736/jcim20111101.CrossRefPubMed
3.
Mahavorasirikul W, Viyanant V, Chaijaroenkul W, Itharat A, Na-Bangchang K: Cytotoxic activity of Thai medicinal plants against human cholangiocarcinoma, laryngeal and hepatocarcinoma cells in vitro. BMC Complement Altern Med. 2010, 10: 55-10.1186/1472-6882-10-55.CrossRefPubMedPubMedCentral
4.
Lee E, Surh YJ: Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Lett. 1998, 134 (2): 163-168. 10.1016/S0304-3835(98)00253-5.CrossRefPubMed
5.
Tatsuta M, Iishi H: Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther. 1993, 7 (4): 459-462.CrossRefPubMed
6.
Patra A, Ghosh A: Amides of Piper chaba. Phytochemistry. 1974, 13 (12): 2889-2890. 10.1016/0031-9422(74)80272-4.CrossRef
7.
Chayamarit K: Thai medicinal plants. 1995, Bangkok: Department of Forestry, 5:
8.
Kubo M, Nogami M, Nishimura M, Moriura T, Arichi S: Origins, processing, and qualities of crude drugs (1). Preventive effects of a Chinese crude drug, Zhu, on experimental stomach ulcer and its pharmacological evaluation. 1. Yakugaku Zasshi. 1983, 103 (4): 442-448.PubMed
9.
Resch M, Heilmann J, Steigel A, Bauer R: Further phenols and polyacetylenes from the rhizomes of Atractylodes lancea and their anti-inflammatory activity. Planta Med. 2001, 67 (5): 437-442. 10.1055/s-2001-15817.CrossRefPubMed
10.
Plengsuriyakarn T, Viyanant V, Eursitthichai V, Tesana S, Chaijaroenkul W, Itharat A, Na-Bangchang K: Study on cytotoxicity, toxicity, and anticancer activity of Zingiber officinale Roscoe against colangiocarcinoma. Phytomedicine (manuscript in press).
11.
Shukla Y, Singh M: Cancer preventive properties of ginger: a brief review. Food Chem Toxicol. 2007, 45 (5): 683-690. 10.1016/j.fct.2006.11.002.CrossRefPubMed
12.
Grzanna R, Lindmark L, Frondoza CG: Ginger - an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005, 8 (2): 125-132. 10.1089/jmf.2005.8.125.CrossRefPubMed
13.
al-Yahya MA, Rafatullah S, Mossa JS, Ageel AM, Parmar NS, Tariq M: Gastroprotective activity of ginger zingiber officinale rosc., in albino rats. Am J Chin Med. 1989, 17 (1-2): 51-56.CrossRefPubMed
14.
Ali BH, Blunden G: Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003, 17 (4): 299-305. 10.1002/ptr.1309.CrossRefPubMed
15.
Cao W, Li XQ, Wang X, Li T, Chen X, Liu SB, Mei QB: Characterizations and anti-tumor activities of three acidic polysaccharides from Angelica sinensis (Oliv.) Diels. Int J Biol Macromol. 2010, 46 (1): 115-122. 10.1016/j.ijbiomac.2009.11.005.CrossRefPubMed
16.
Zheng GQ, Kenney PM, Lam LK: Anethofuran, carvone, and limonene: potential cancer chemopreventive agents from dill weed oil and caraway oil. Planta Med. 1992, 58 (4): 338-341. 10.1055/s-2006-961480.CrossRefPubMed
17.
Mohamad RH, El-Bastawesy AM, Abdel-Monem MG, Noor AM, Al-Mehdar HA, Sharawy SM, El-Merzabani MM: Antioxidant and anticarcinogenic effects of methanolic extract and volatile oil of fennel seeds (Foeniculum vulgare). J Med Food. 2011, 14 (9): 986-1001. 10.1089/jmf.2008.0255.CrossRefPubMed
18.
Oh H, Lee HS, Kim T, Chai KY, Chung HT, Kwon TO, Jun JY, Jeong OS, Kim YC, Yun YG: Furocoumarins from Angelica dahurica with hepatoprotective activity on tacrine-induced cytotoxicity in Hep G2 cells. Planta Med. 2002, 68 (5): 463-464. 10.1055/s-2002-32075.CrossRefPubMed
19.
Ngo NT, Nguyen VT, Vo HV, Vang O, Duus F, Ho TD, Pham HD, Nguyen LH: Cytotoxic coumarins from the bark of Mammea siamensis. Chem Pharm Bull (Tokyo). 2010, 58 (11): 1487-1491. 10.1248/cpb.58.1487.CrossRef
20.
Chirathaworn C, Kongcharoensuntorn W, Dechdoungchan T, Lowanitchapat A, Sa-nguanmoo P, Poovorawan Y: Myristica fragrans Houtt. methanolic extract induces apoptosis in a human leukemia cell line through SIRT1 mRNA downregulation. J Med Assoc Thai. 2007, 90 (11): 2422-2428.PubMed
21.
Banerjee S, Das S: Anticarcinogenic effects of an aqueous infusion of cloves on skin carcinogenesis. Asian Pac J Cancer Prev. 2005, 6 (3): 304-308.PubMed
22.
Rooney S, Ryan MF: Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines. Anticancer Res. 2005, 25 (3B): 2199-2204.PubMed
23.
Shoieb AM, Elgayyar M, Dudrick PS, Bell JL, Tithof PK: In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol. 2003, 22 (1): 107-113.PubMed
24.
Gali-Muhtasib H, Diab-Assaf M, Boltze C, Al-Hmaira J, Hartig R, Roessner A, Schneider-Stock R: Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Int J Oncol. 2004, 25 (4): 857-866.PubMed
25.
Roepke M, Diestel A, Bajbouj K, Walluscheck D, Schonfeld P, Roessner A, Schneider-Stock R, Gali-Muhtasib H: Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol Ther. 2007, 6 (2): 160-169. 10.4161/cbt.6.2.3575.CrossRefPubMed
26.
Wilson-Simpson F, Vance S, Benghuzzi H: Physiological responses of ES-2 ovarian cell line following administration of epigallocatechin-3-gallate (EGCG), thymoquinone (TQ), and selenium (SE). Biomed Sci Instrum. 2007, 43: 378-383.PubMed
27.
Sethi G, Ahn KS, Aggarwal BB: Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. 2008, 6 (6): 1059-1070. 10.1158/1541-7786.MCR-07-2088.CrossRefPubMed
28.
Ozaki Y, Soedigdo S, Wattimena YR, Suganda AG: Antiinflammatory effect of mace, aril of Myristica fragrans Houtt., and its active principles. Jpn J Pharmacol. 1989, 49 (2): 155-163. 10.1254/jjp.49.155.CrossRefPubMed
29.
Houghton PJ, Zarka R, De las Heras B, Hoult JR: Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 1995, 61 (1): 33-36. 10.1055/s-2006-957994.CrossRefPubMed
30.
Chao WW, Hong YH, Chen ML, Lin BF: Inhibitory effects of Angelica sinensis ethyl acetate extract and major compounds on NF-kappaB trans-activation activity and LPS-induced inflammation. J Ethnopharmacol. 2010, 129 (2): 244-249. 10.1016/j.jep.2010.03.022.CrossRefPubMed
31.
Likhitwitayawuid K, Sawasdee K, Kirtikara K: Flavonoids and stilbenoids with COX-1 and COX-2 inhibitory activity from Dracaena loureiri. Planta Med. 2002, 68 (9): 841-843. 10.1055/s-2002-34403.CrossRefPubMed
32.
Kim CM, Heo MY, Kim HP, Sin KS, Pachaly P: Pharmacological activities of water extracts of Umbelliferae plants. Arch Pharm Res. 1991, 14 (1): 87-92. 10.1007/BF02857821.CrossRefPubMed
33.
Abdel-Fattah AM, Matsumoto K, Watanabe H: Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur J Pharmacol. 2000, 400 (1): 89-97. 10.1016/S0014-2999(00)00340-X.CrossRefPubMed
34.
Zhu HL, Ji JL, Huang XF: Curcumin and its formulations: potential anti-cancer agents. Anticancer Agents Med Chem. 2011,
35.
John S, Nikhil S, Yaswanth J, Bhaskar A, Amit A, Sudha S: Analgesic property of different extracts of Curcuma longa (Linn): an experimental study in animals. J Nat Remed. 2009, 9 (1): 116-120.
36.
Tuorkey M, Karolin K: Anti-ulcer activity of curcumin on experimental gastric ulcer in rats and its effect on oxidative stress/antioxidant, IL-6 and enzyme activities. Biomed Environ Sci. 2009, 22 (6): 488-495. 10.1016/S0895-3988(10)60006-2.CrossRefPubMed
37.
OECD: Acute oral toxicity, guideline 420, the OECD guideline for testing of chemical. 2001
38.
Chaimuangraj S, Thamavit W, Tsuda H, Moore MA: Experimental investigation of opisthorchiasis-associated cholangiocarcinoma induction in the Syrian hamster - pointers for control of the human disease. Asian Pac J Cancer Prev. 2003, 4 (2): 87-93.PubMed
39.
Dunham NW, Miya TS: A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (Baltim). 1957, 46 (3): 208-209.CrossRef
40.
James O, Friday EA, Unekwuojo EG: Antihypertensive Effect of Methanol Extract of Napoleona imperialis (p. beauv) in Adrenaline Induced Hypertensive Albino Rats. Inter J Biochem Res Rev. 2011, 1 (2): 47-57.CrossRef
41.
Woolfe G, MacDonald AD: The evaluation of the analgesic action of pethidine hydrochloride (Demerol). Journal of Pharmacology and Experimental Therapeutics. 1944, 80 (3): 300-307.
42.
Koster R, Anderson M, De Beer EJ: Acetic acid for analgesic screening. Fed Proc. 1959, 18: 412-416.
43.
Winter CA, Risley EA, Nuss GW: Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 1962, 111: 544-547.CrossRefPubMed
44.
De Pasquale R, Germano MP, Keita A, Sanogo R, Iauk L: Antiulcer activity of Pteleopsis suberosa. J Ethnopharmacol. 1995, 47 (1): 55-58. 10.1016/0378-8741(95)01256-D.CrossRefPubMed
45.
Kauffman GL, Grossman MI: Prostaglandin and cimetidine inhibit the formation of ulcers produced by parenteral salicylates. Gastroenterology. 1978, 75 (6): 1099-1102.PubMed
Metadata
Title
Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models
Authors
Tullayakorn Plengsuriyakarn
Vithoon Viyanant
Veerachai Eursitthichai
Porntipa Picha
Piengchai Kupradinun
Arunporn Itharat
Kesara Na-Bangchang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2012
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-12-23

Other articles of this Issue 1/2012

BMC Complementary Medicine and Therapies 1/2012 Go to the issue

Research article

Isorhamnetin 3-O-robinobioside from Nitraria retusa leaves enhance antioxidant and antigenotoxic activity in human chronic myelogenous leukemia cell line K562

Research article

Laxative effects of partially defatted flaxseed meal on normal and experimental constipated mice

Research article

Ethanol extract of Gleditsia sinensis thorn suppresses angiogenesis in vitro and in vivo

Research article

The cardioprotective effect of danshen and gegen decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury

Research article

Screening of anti-dengue activity in methanolic extracts of medicinal plants

Study protocol

Transcutaneous vagus nerve stimulation for the treatment of depression: a study protocol for a double blinded randomized clinical trial